To better understand the effect of DNMT3A mutations in CN‐AML, we compared the clinical impact of NPM1mutFLT3‐ ITDmut and IDH1/IDH2mut when with or without the genetic context of DNMT3A mutations. The gene discussed is IDH1; the disease is acute myeloid leukemia.